--- RealRate company pick: Monopar Therapeutics ---
Monopar Therapeutics has been Top Rated in the US Pharmaceutical ranking 2026: Rank 2 of 178.
We analyzed the company's strengths and weaknesses using our award-winning explainable AI. The strengths are depicted in our colored causal graph that can be downloaded at https://www.realrate-archive.com/us_pharma/2025/report/0001645469_2026_Monopar_Therapeutics.pdf

The complete ranking list is available at https://realrate.ai/rankings/us_pharma/2026

RealRate is an international AI-driven financial rating agency, based in Santa Clara and Berlin. We are making AI explainable in the finance domain. We cover 30 US industries and 3000 stock-listed companies. All ratings are publicly available.
#ratings #ai